Related content

Therapeutic management of allergic diseases

By Watelet Jean-Baptiste   Gillard Michel   Benedetti Margherita Strolin   Lelièvre Bénédicte   Diquet Bertrand  

Drug Metabolism Reviews, Vol. 41, Iss. 3, 2009-08 ,pp. : 301-343

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Flavonoids on Allergic Diseases

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 5, 1970-01 ,pp. : 374-381

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Allergic Diseases

By  

Current Gene Therapy, Vol. 9, Iss. 3, 2009-06 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis

By Giusti Betti   Gori Anna Maria   Marcucci Rossella   Abbate Rosanna  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 393-407

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical application

By Piatkov Irina   Jones Trudi   Rochester Colin  

Pharmacogenomics, Vol. 10, Iss. 12, 2009-12 ,pp. : 1987-1994

Future Medicine

Access to resources Recommend Favorite